FDA Investigator Joslyn K Brunelle, PhD

Joslyn K Brunelle, PhD has conducted inspections on 3 sites in 1 countries as of 01 Oct 2018. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
3
Last Inspection Date:
01 Oct 2018
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Joslyn K Brunelle, PhD:
Alan L Truong, Andrew J Barrowcliff, Andrew W Harmon, Angel K Sandhu, Anh M Lac, Ashar P Parikh, Bo Chi, PhD, Brian A Roelofs, Candace Y Gomez Broughton, Carl Lee, Carolyn A Renshaw, CDR Rochelle B Young, RPh, MSA, Charles Yuanchia Kuo, PhD, Cristina Ausin Moreno, PhD, Diane L Raccasi, Dilip Devineni, PhD, Dr. Zhou Chen (nmi), MD PhD, Dustin P Tran, Eboni S Funderburk, Edwin Jao, Eileen A Liu, Emilie E Kahn, Emmanuel Adu Gyamfi, PhD, Eric M Mueller, PharmD, Esther C Broner, PhD, Hamet M Toure, PharmD MPH, Henry K Lau, Hung H Do, MS, Hyung Yul Lee, Ian L Mcwilliams, Jacob G Lutz, James A Lane, Jeffrey D Meng, Jeffrey M Watson, Jill J Tillman, Jolanna A Norton, Jon P Antoniou, Joseph A Piechocki, Kalavati Suvarna, PhD, Kevin P Foley, Kula N Jha, Lance Mde Souza, MBA, Laura Fontan, MS, Lauren N Howard, Laurie Graham, LCDR Sean Byrd, Logan T Williams, Maria Cruz Fisher, Massod Rahimi, PhD, Meisha R Sampson, Meisha Waters, Michael Shanks, MS, Michele L Forster, PhD, Michele L Glendenning, Michele Perry Williams, Monica E Murie, Muna Algharibeh, Nicholas L Paulin, Paula A Trost, Prabhu P Raju, Rabia Ballica, PhD, Rafeeq A Habeeb, Raymond T Oji, Richard Ledwidge (nmi), PhD, Robert Barbosa, Robert J Ham, Robert M Barbosa, Sandra A Boyd, Sargum C Sood, Scott R Nichols, PhD, Sherri J Jackson, Sidney B Priesmeyer, Sneha S Patel, Steven D Kehoe, Tara L Greene, Tara L King, Thomas J Arista, Thomas R Withers, Timothy J Schmidt, Uduak M Inokon, Uttaniti Limchumroon (Tom), Vaishali J Patel, Warren J Lopicka, Wayne E Seifert, Wendy G Tan, PhD, William V Millar, Xiaoshi N Wang, Yanming An, PhD, Ying Xin Fan, PhD, Yiyue Zhang (nmi), PhD, Yongmin Liu, Yuan Chia Kuo, Zhang Zhao, PhD

Joslyn K Brunelle, PhD's Documents

Publish Date Document Type Title
October, 2018 FDA 483 Patheon Biologics LLC - Form 483, 2018-10-09
December, 2017 EIR BioMarin Pharmaceutical Inc. - EIR, 2017-12-14
October, 2013 EIR Catalent Indiana, LLC - EIR, 2013-10-25
October, 2013 FDA 483 Catalent Indiana, LLC - Form 483, 2013-10-25
December, 2017 FDA 483 BioMarin Pharmaceutical Inc. - Form 483, 2017-12-14

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more